Cita APA

Jara, M., Aquilina, T., Aupperle, P., & Rabinowicz, A. L. (2015). Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States. Drug Healthc Patient Saf.

Chicago Style Citation

Jara, Michele, Thomas Aquilina, Peter Aupperle, i Adrian L. Rabinowicz. "Safety Profile of Dalfampridine Extended Release in Multiple Sclerosis: 5-year Postmarketing Experience in the United States." Drug Healthc Patient Saf 2015.

Cita MLA

Jara, Michele, Thomas Aquilina, Peter Aupperle, i Adrian L. Rabinowicz. "Safety Profile of Dalfampridine Extended Release in Multiple Sclerosis: 5-year Postmarketing Experience in the United States." Drug Healthc Patient Saf 2015.